Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from human MYLIP.
Synthetic
(Accession #: NP_037394) The MYLIP Blocking Peptide is derived from Synthetic. The MYLIP Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-104044 |
| Réf. fabricant | 18288923 |
| Gene ID (Entrez) | 29116 |
| Espèces | Human |
| Numéro d’adhésion | Q8WY64 |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Lyophilized with sterile distilled water. |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-54903. This Synthetic Peptide is Designed for Use in an Antibody Competition Assay with Its Corresponding Antibody. Use of This Product in Any Other Assay Has Not Yet Been Tested. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | band 4.1 superfamily member BZF1, BZF1, cellular modulator of immune recognition (c-MIR), EC 6.3.2.-, Idol, IDOLmyosin regulatory light chain-interacting protein, Inducible degrader of the LDL-receptor, MIRE3 ubiquitin-protein ligase MYLIP, myosin regulatory light chain interacting proteinE3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor |
| Symbole de gène(s) | MYLIP |
| Type de produit | MYLIP |
| Quantité | 100 μL |
| État réglementaire | RUO - research use only |
